Physician profile
Michael K Fishman
NPI 1447454269
$38,703.06
in general payments reported to CMS, 2019-2025
35 companies · $290 in 2025
The $290 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $3,850 · 2021: $14K · 2022: $3,900 · 2023: $3,402 · 2024: $206 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Food and Beverage: $898.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Food and Beverage | $898.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $14,475.16 | 2021-2023 | Intellis Adaptivestim |
| Intuitive Surgical, INC. | $12,623.83 | 2019-2023 | Davinci Xi |
| The Institute of Musculoskeletal Science and Education | $5,225.00 | 2020-2021 | |
| Foundation Fusion Solutions, LLC | $3,150.00 | 2019 | |
| W. L. Gore & Associates, INC. | $595.94 | 2021-2025 | Gore Enform Preperitoneal Biomaterial, Gore Synecor Biomaterial, Gore Enform Intraperitoneal Biomaterial |
| Camber Spine Technologies LLC | $484.44 | 2020-2022 | |
| Medtronic USA, INC. | $362.92 | 2019-2020 | |
| Vertos Medical, INC. | $258.80 | 2022-2024 | Mild Device Kit |
| Janssen Pharmaceuticals, INC | $245.32 | 2019-2022 | |
| Stimwave Technologies Incorporated | $243.63 | 2019-2020 | |
| Aroa Biosurgery Incorporated | $141.52 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $87.59 | 2019-2020 | |
| Baxter Healthcare | $69.55 | 2019-2021 | |
| Daiichi Sankyo INC. | $61.79 | 2019-2021 | |
| Novo Nordisk INC | $58.56 | 2023 | Wegovy |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $56.04 | 2019-2020 | |
| Tela Bio, INC. | $51.57 | 2019-2020 | |
| Davol INC. | $50.96 | 2019-2025 | Arista |
| Si-Bone, INC. | $45.90 | 2025 | |
| Vertiflex, INC. | $44.00 | 2019 | |
| Teleflex LLC | $42.29 | 2021-2023 | Titan Sgs Standard Gastric Stapler |
| Assertio Therapeutics, INC. | $42.12 | 2019-2020 | |
| Covidien LP | $40.53 | 2019 | |
| Mml US, INC. | $36.07 | 2025 | Reactiv8 |
| Endogastric Solutions, INC | $31.08 | 2024 | Esophyx |
| Shire North American Group INC | $26.74 | 2019 | |
| Olympus America INC. | $24.73 | 2019 | |
| Carlsmed, INC. | $23.61 | 2022 | |
| Abbvie INC. | $23.28 | 2021 | |
| Arbor Pharmaceuticals, INC. | $22.08 | 2019 | |
| Getinge USA Sales, LLC | $20.77 | 2019 | |
| Stryker Corporation | $15.07 | 2021 | |
| Focal Therapeutics, INC. | $12.05 | 2019 | |
| Forte Bio-Pharma LLC | $10.12 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Fishman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.